Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 71 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Mantzoros, Christos S  [Clear All Filters]
Journal Article
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Triantafyllou G. Α., & Mantzoros C. S. (2016).  Activin A and follistatin in patients with nonalcoholic fatty liver disease.. Metabolism. 65(10), 1550-8.
Anastasilakis, A. D., Polyzos S. A., Rodopaios N. E., Makras P., Kumar A., Kalra B., et al. (2022).  Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.. Metabolism. 141, 155397.
Boutari, C., Polyzos S. A., & Mantzoros C. S. (2021).  Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward.. Metabolism. 122, 154781.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2016).  Adipokines in nonalcoholic fatty liver disease.. Metabolism. 65(8), 1062-79.
Polyzos, S. A., & Mantzoros C. S. (2016).  Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.. Metabolism. 65(9), 1297-306.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Margouta A., & Mantzoros C. S. (2015).  Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease.. Endocrine. 49(2), 560-2.
Anastasilakis, A. D., Polyzos S. A., Savvidis M., Anastasilakis D. A., Sarridimitriou A., Kumar A., et al. (2023).  Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study.. Endocrine. 81(3), 573-578.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Migdalis I., et al. (2014).  Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study.. Biomarkers. 19(8), 660-6.
Anastasilakis, A. D., Polyzos S. A., Skouvaklidou E. C., Kynigopoulos G., Saridakis Z. G., Apostolou A., et al. (2016).  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.. Metabolism. 65(10), 1459-65.
Anastasilakis, A. D., Polyzos S. A., Saridakis Z. G., Kynigopoulos G., Skouvaklidou E. C., Molyvas D., et al. (2014).  Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.. J Clin Endocrinol Metab. 99(9), 3247-55.
Anastasilakis, A. D., Koulaxis D., Kefala N., Polyzos S. A., Upadhyay J., Pagkalidou E., et al. (2017).  Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD. Metabolism. 73, 1-8.
Polyzos, S. A., Aronis K. N., Kountouras J., Raptis D. D., Vasiloglou M. F., & Mantzoros C. S. (2016).  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.. Diabetologia. 59(1), 30-43.
Polyzos, S. A., Kang E. Seok, Tsochatzis E. A., Kechagias S., Ekstedt M., Xanthakos S., et al. (2020).  Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.. Metabolism. 113, 154413.
Polyzos, S. A., Kang E. Seok, Boutari C., Rhee E-J., & Mantzoros C. S. (2020).  Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.. Metabolism. 154203.
Polyzos, S. A., & Mantzoros C. S. (2021).  Diabetes mellitus: 100 years since the discovery of insulin.. Metabolism. 118, 154737.
Markozannes, G., Ntzani E. E., Tsapas A., Mantzoros C. S., Tsiara S., Xanthos T., et al. (2022).  Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events.. Clin Nutr. 41(4), 923-930.
Mintziori, G., Nigdelis M. P., Mathew H., Mousiolis A., Goulis D. G., & Mantzoros C. S. (2020).  The effect of excess body fat on female and male reproduction.. Metabolism. 154193.
Foo, J-P., Polyzos S. A., Anastasilakis A. D., Chou S., & Mantzoros C. S. (2014).  The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.. J Clin Endocrinol Metab. 99(11), E2252-8.
Boutari, C., Pappas P. D., Mintziori G., Nigdelis M. P., Athanasiadis L., Goulis D. G., et al. (2020).  The effect of underweight on female and male reproduction.. Metabolism. 107, 154229.
Polyzos, S. A., Kountouras J., Mantzoros C. S., Polymerou V., & Katsinelos P. (2017).  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.. Diabetes Obes Metab. 19(12), 1805-1809.
Polyzos, S. A., Perakakis N., & Mantzoros C. S. (2019).  Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.. Metabolism. 96, 66-82.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Triantafilli M., et al. (2016).  Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.. Leuk Lymphoma. 57(3), 577-84.
Raptis, D. D., Mantzoros C. S., & Polyzos S. A. (2023).  Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease.. Ther Clin Risk Manag. 19, 77-96.
Seo, Y-G., Polyzos S. A., Park K-H., & Mantzoros C. S. (2023).  Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population.. Clin Gastroenterol Hepatol.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.